You will play a key role within the Provision and Forecasting team, which manages Impairment stock and Stress Testing Regulatory submissions for a key portfolio. Key activities include but are not limited to monthly impairment reporting; review and challenge of the existing suite of IFRS 9 models; development and maintenance of analytical dashboards and MI; day-to-day management of up to 1 direct report.
The Role:
* Overseeing the IFRS 9 model outputs, Budgeting and/or stress testing exercises model outputs (such as ICAAP - Internal Capital Adequacy Assessment Process, ACS - Annual Cyclical Scenario, EBA - European Banking Authority, and internal scenarios)
* Leading the preparation of materials and presenting provisions/stress testing exercise results to the relevant governance forums/committees
* Engaging with other risk areas such as forecasting, portfolio management, collections, finance, capital planning, climate risk, and interaction with UK and European regulators regarding stress testing activities
* Engaging regularly with internal/external auditors to ensure audit points are addressed and closed in a timely manner
* Involving in the review and challenge of the next-generation credit risk provisioning & stress testing models
* Establishing robust governance and control frameworks and flagging issues that could lead to misstatement in the results
The Candidate;:
* Extensive knowledge and experience of IFRS9 and undertaking stress testing and forecasting exercises within retail banking
* Extensive experience using SAS for in-depth analysis
It would also be nice for you to have:
* Excellent analytical and communication skills.
* Ability to draw conclusions based on analytic results, present complex concepts and results tailored to the audience
* Understand how results are used by both internal customers (Finance MI and Capital Planning, etc.) and external customers (PRA and EBA - Prudential Regulation Authority)
* Has a good understanding of both the Accounting Standards that impact the provisioning processes and Regulatory Guidance that impacts the capital calculations
* Actively seeks to either reduce or remove risk when weaknesses in either the methodology or the processes are identified